Pleiotropic effects of survivin in vascular endothelial cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Microvascular Research

• Publication date

  2016-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mvr.2016.06.004PMID 27373518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiation-induced microrna-622 causes radioresistance in colorectal cancer cells by down-regulating Rb

  2015cited by this paper
• Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.

  2015cited by this paper
• Lower extremity amputation in peripheral artery disease: improving patient outcomes

  2014cited by this paper
• Expression of survivin in human oocytes and preimplantation embryos.

  2013cited by this paper
• Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms.

  2013cited by this paper
• Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.

  2013cited by this paper
• Clinical Application of Vascular Regenerative Therapy for Peripheral Artery Disease

  2013cited by this paper
• Aurora B kinase phosphorylates and instigates degradation of p53

  2012cited by this paper
• Expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue.

  2012cited by this paper
• Treatment of peripheral arterial disease using stem and progenitor cell therapy.

  2011cited by this paper
• RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.

  2011cited by this paper
• MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE

  2011cited by this paper
• Quality of life among lower extremity peripheral arterial disease patients who have undergone endovascular or surgical revascularization: a case-control study.

  2010cited by this paper
• Regenerative therapy in peripheral artery disease.

  2009cited by this paper
• Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis.

  2008cited by this paper
• Endovascular therapy for critical limb ischemia

  2008cited by this paper
• Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality.

  2008cited by this paper
• Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases.

  2008cited by this paper
• Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.

  2008cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• The case for survivin as a regulator of microtubule dynamics and cell-death decisions.

  2006cited by this paper
• The case for Survivin as mitotic regulator.

  2006cited by this paper
• Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation.

  2006cited by this paper
• Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

  2005cited by this paper
• Survivin: a protein with dual roles in mitosis and apoptosis.

  2005cited by this paper
• Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.

  2005cited by this paper
• Angiotensin II induces MMP-2 in a p47phox-dependent manner.

  2005cited by this paper
• Chromosomal passengers: the four-dimensional regulation of mitotic events

  2004cited by this paper
• Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies.

  2004cited by this paper
• Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.

  2004cited by this paper
• Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy

  2003cited by this paper
• Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.

  2003cited by this paper
• Expression of Survivin and Caspase-3 in Gastric Cancer

  2003cited by this paper
• Survivin, versatile modulation of cell division and apoptosis in cancer

  2003cited by this paper
• Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53*

  2002cited by this paper
• Inhibitor of apoptosis protein survivin regulates vascular injury

  2002cited by this paper
• Regulation of microtubule stability and mitotic progression by survivin.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The molecular basis and potential role of survivin in cancer diagnosis and therapy.

  2001cited by this paper
• Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway*

  2000cited by this paper
• Survivin does not inhibit caspase-3 activity.

  2000cited by this paper
• Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells.

  1999cited by this paper
• Mechanisms of G2 arrest in response to overexpression of p53.

  1999cited by this paper
• p53 regulates a G2 checkpoint through cyclin B1.

  1999cited by this paper
• IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

  1998cited by this paper
• p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

  1995cited by this paper
• Send correspondence to:

  1992cited by this paper
• p53 is associated with p34cdc2 in transformed cells.

  1990cited by this paper

• Survivin modulates stiffness-induced vascular smooth muscle cell motility

  2025cites this paper
• Survivin modulates stiffness-induced vascular smooth muscle cell motility

  2024cites this paper
• Association of BIRC5 Gene Polymorphism with the Collateral Circulation and Severity of Large Artery Atherosclerotic Stroke

  2022cites this paper
• Combined Analysis of Surface Protein Profile and microRNA Expression Profile of Exosomes Derived from Brain Microvascular Endothelial Cells in Early Cerebral Ischemia

  2021cites this paper
• Multimodal Photoacoustic Imaging‐Guided Regression of Corneal Neovascularization: A Non‐Invasive and Safe Strategy

  2020cites this paper
• Transmural pressure drives proliferation of human arterial smooth muscle cells via mechanism associated with NADPH oxidase and Survivin.

  2019cites this paper
• Wall shear stress promotes intimal hyperplasia through the paracrine H2O2‐mediated NOX‐AKT‐SVV axis

  2018cites this paper
• Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma

  2017cites this paper